FDA Investigator Calvin K Cook
Calvin K Cook has conducted inspections on 194 sites in 8 countries as of 18 Jul 2011. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
194
Last Inspection Date:
18 Jul 2011
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
India,
Ireland,
Korea (Republic of),
France,
Australia,
Taiwan
FDA Investigators that have inspected at least one site in common with Calvin K Cook:
Adrian D Land,
Adrianna G Vargo,
Akbar J Zaidi,
Alexandra A Carrico,
Althea A Williams,
Amanda L Baskin,
Amina Bashir,
Amy S Graf,
Andrea D Swingle,
Andrew H Paeng,
Antonio M Hampton,
Ashleigh P Barkans,
Ava M Bowman,
Barbara D Bennett,
Bei Y He,
Benjamin J Smith,
Bernard P Heidt,
Bleta Vuniqi,
Brandi N Mcgrady,
Brenda L Reihing,
Brian J Mundo,
Brian M Campbell,
Brian M Marosan,
Brian P Hendrickson,
Brian P Putz,
Brian R Yaun,
Brittany M Lowe,
Bryan J Love,
Byron Ho, DVM,
CDR Kimberly Y Martin,
CDR Sean T Creighton,
Charles E Frelix,
Charles L Larson,
Charles M Spyr,
Chase S Baldwin,
Chelsea J Falkowski,
Chelsea J Snider,
Christi L Bellmore,
Christopher J Hurst,
Corrine M Carter,
Crystal M Young Lewis,
Cynthia A Harris, MD, RN,
Cynthia L Aycock,
Cynthia Li,
Daniel J Gorski,
Danny Tuntevski,
Dariusz Galezowski,
David A Paterson,
David J Gasparovich,
Dawn C Olenjack,
Debara R Reese,
Deborah A Nebenzahl,
Dennis R Downer,
Dipesh K Shah,
Dolores Harper,
Donna K Speer,
Edwardstine J Reese,
Emest F Bizjak,
Emily J Orban,
Eric E Joneson,
Eric M Padgett,
Eric S Pittman,
Francis J Eng,
Frank Verni,
Gary Durbiel Goldner,
Gary L Zaharek,
George G Calafactor,
Hans T Meyers,
Ifueko Osemwota,
Jacob A Clark,
James A Lane,
James D Hildreth,
James E Szelc,
James M Odonnell,
James N Rench,
Jeff A Gard,
Jeffrey A Sommers,
Jennifer R Johnson,
Jocelyn M Muggli,
John A Hall,
John A Sciacchitano,
John D Jaworski,
John E Emmert,
John N Woodall,
Joie A Navarrete,
Joseph R Strelnik,
Julia A Avery,
Juliane C Lessard,
K Gonzlez,
Karen A Coleman,
Karl D Hezel,
Kathryn A Guardiola,
Kathryn G Brown,
Kelley L Clark,
Kennita Riddick,
Kinh Q Mac,
Kristina Mezin,
Kristina Nastovski,
Kunapuli T Madhusudhan,
Kwong P Lee,
Larry K Austin,
Laureen M Geniusz,
Lauren E Burke,
Lauren E Sexton,
LCDR Anastasia M Piliafas Brown,
LCDR Matthew R Mcnew, MPH, REHS/RS,
Leigh Anne Myers,
Leonard H Lavi,
Lewis K Antwi,
Linda S Jozefiak,
Lisa M Thursam,
Lori J Silverstein,
Lorna F Jones,
LTJG Aaron B Otis,
Maribeth G Grattan,
Maribeth G Niesen,
Marlon K Turner,
Martin R Vowell,
Meisha R Sampson,
Meisha Waters,
Melanie W Pishnery,
Melina Lrodriguez Upton,
Misty D Harvey,
Monica J Wilkins,
Msdap Gonzlezk,
Muna Algharibeh,
Myra K Casey,
Nancy A Bellamy,
Natalie A Mickelsen, DVM,
Neal D Singletary, PhD,
Neali H Lucas,
Nelson,
Norman Wong,
Patricia H Dlugosz,
Patrick B Cummings,
Rafeeq A Habeeb,
Ralph Jerndal,
Rasha Bamieh,
Rebecca E Dombrowski,
Richard T Riggie,
Robert G Ruff,
Robert M Barbosa,
Robert P Neligan,
Rodney B Ross,
Rohn R Robertson,
Rosanna M Goodrich,
Rupa Pradhan,
Ryan J Benedict,
Sara M Onyango,
Sargum C Sood,
Scott A Nabe,
Shannon A Gregory,
Shaquenta Y Perkins,
Sherri N Rohlf, MD,
Stanley B Eugene, BS, BME,
Suyang Qin,
Talmane J Fisher,
Tarsha T Mcclendon,
Thai T Duong,
Theodore N Sietsema,
Thomas A Peter,
Thursaml,
Tony T Yang,
Tracey L Siebesma,
Travis S Bradley,
Vera M Anderson,
Vesa Vuniqi,
Vickie L Adkins,
William D Tingley,
William G Nelson,
William R Brubaker,
Xiaojun Yan,
Yehualashet A Gessesse
Calvin K Cook's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2005 | EIR | DePuy Orthopaedics, Inc. - EIR, 2005-01-19 |
April, 2011 | FDA 483 | Symbios Medical Products, LLC - Form 483, 2011-04-22 |
May, 2010 | EIR | Nestle-usa, Inc. - EIR, 2010-05-21 |
October, 2010 | FDA 483 | Caire, Inc. - Form 483, 2010-10-08 |
January, 2008 | FDA 483 | DePuy Orthopaedics, Inc. - Form 483, 2008-01-22 |
March, 2007 | FDA 483 | Roche Diagnostics Operations, Inc. - Form 483, 2007-03-09 |
May, 2009 | FDA 483 | Hologic, Inc. - Form 483, 2009-05-20 |
September, 2009 | FDA 483 | King Systems Corp. dba Ambu, Inc. - Form 483, 2009-09-04 |
January, 2008 | EIR | DePuy Orthopaedics, Inc. - EIR, 2008-01-22 |
April, 2005 | FDA 483 | CrestLab, Inc. - Form 483, 2005-04-28 |
February, 2009 | FDA 483 | Sunrise Medical US, LLC - Form 483, 2009-02-09 |
September, 2009 | FDA 483 | Century Pharmaceuticals, Inc. - Form 483, 2009-09-10 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more